FDA Investigator Joel D Martinez

Joel D Martinez has conducted inspections on 338 sites in 25 countries as of 28 Nov 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

338

Last Inspection Date:

28 Nov 2018

Investigator Role:

FDA Investigation Participant

Redica ID:

100007445

Countries of Inspections:

United States of America, Italy, Ecuador, India, Peru, Austria, Canada, Russian Federation, Portugal, United Kingdom of Great Britain and Northern Ireland, South Africa, Argentina, France, Brazil, Germany, Lithuania, Australia, Hungary, Dominican Republic, Costa Rica, Denmark, Czechia, Panama, Chile, Poland

FDA Investigators that have inspected at least one site in common with Joel D Martinez:

Akbar J Zaidi, Albert F Peacock, PhD, Allen F Hall, Amanda J White, Andrea A Branche, Andrew J Barrowcliff, Andrew R Wasko, Anh M Lac, Anitha Palamakula Govada, Anthony E Keller, RPh, Anthony J Ladner, Anya Dlockett Evans, Arsen Karapetyan, Audrey J Yarbrough, Barbara M Frazier, Bhanu M Kannan, Bijoy Panicker, Blondell W Johnson, Bobbi J Miller, Brenda G Stewart Munoz, Brian J Ryan, Byungja E Marciante, Camerson E Moore, Camille D Brown, Charles D Brown, Christina D Mello, Christopher D Rush, Christopher J Smith, Connie L Hannon Rabel, Conrad J Ledet, Constance M Dobbins, Corrine M Carter, Courtney N Long, Cynthia A Harris, MD, RN, Cynthia F Kleppinger, MD, Daniel J Lahar, Daniel L Aisen, Daniel S Fam, Daniell Gill, Jr, Danielle Lyke, Danny D Horner, Darla J Christopher, David M Beltran, David R Heiar, Denise L Burosh, Deniza Karacic, Diana L Ayala, Diane Cvan Leeuwen, Diane L Raccasi, Dr. Barbara D Paul, PhD, Dr. Jason R Caballero, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Edward D Edmiston, Edward D Mcdonald, Eileen A Liu, Elisa M Fleming, Ellen J Tave, Elvia J Cervantes, Emilio O Escobar, Eric M Mueller, PharmD, Floyd D Herd, Frederic W French, III, H Ljamilla Selby, Habacuc V Barrera, Hala L Selby, Hugh M Mcclure, II, Hung V Le, Iris C Macinnes, J Elkins, Jacey Roy, James C Henry, James H Robinson, James R Montero, Janet B Abt, Janete F Guardia, Janice M Hickok, Jd Young, Jeanne D Shaffer, Jeffrey R Wooley, Jennifer O Dowdy, Jeremy W Rotton, Joanne M Schlossin, Jocelyn C Turner, Jodi M Gatica, Johann M Fitch, Jonaida Estevez Martinez, Jose A Lopez, Jose Martinez, Jr, Karen C Daugherty, Karen M Cooper, Karen M Kondas, Kathleen Chmura Shaffer, Kathryn A Krentz, Kelly D Sheppard, Khairy W Malek, MD, Kirtida Patel, Kristen Nickens, PhD, Lakecha N Lewis, Lakshmi Narasimhan, PhD, Lan T Tran, Lance D Johnson, Lance Mde Souza, MBA, Latorie S Jones, Laura Fontan, MS, Laurie Nelson, Leighton Kn Gai, Lillie M Young, Linda F Murphy, Linda M Hoover, Linda Thai, Lindsey Brown, PhD, Lisa A Doyle, Lisa M Puttonen, Lloyd D Payne, Lorie S Hannappel, Lourdes Valentin Aponte, Lucas B Leake, Maira P Brading, Maotang Zhou, PhD, Marc R Dickens, Margaret M Annes, Maria Gutierrez Lugo, PhD, Marilyn S Babu, Mark W Babbitt, Marla A Cassidy, Martin K Yau, PhD, Merry Christie, PhD, Michael Shanks, MS, Michele L Obert, Michelle A Krayer, Mike M Rashti, Mohsen Rajabi Abhari, FDA, Monique S Frazier, Muralidhara B Gavini, PhD, Myra K Casey, Nancy A Bellamy, Neali H Lucas, Ni Aye Khin, MD, Nicole M Bell, Patrice S Hall, Patrick D Stone, MS, Patrick J Mcneilly, Patty P Kaewussdangkul, Paula J Perry, Philip M Steele, PhD, Phillip D Waldron, Ralph H Vocque, Rebecca Co Bryan, Rebecca Rodriguez, Regina T Brown, Rene R Ramirez, Reyes Candau Chacon, PhD, Rhonda L Dash, Rian L Pope, Richard T Riggie, Richard W Berning, Robert D Tollefsen, Robert M Tillman, Robert T Lorenz, Roy Baby, Ruben C Ayala, PharmD, S Lori Brown, PhD MPH, Saijal P Naik, Sandra A Hughes, Sandy J Ziegler, Sarah Kennett, PhD, Scott B Laufenberg, Scott T Ballard, Selina M Mata, Shawn E Larson, Sherri N Rohlf, MD, Sherrie L Krolczyk, Shirley J Berryman, Srinivas R Chennamaneni, PhD, Stephen D Brown, Stephen L Beekman, Stephen R Souza, Susanne M Richardson, MS RAC, Suzanne G Demko, Terrance L Thomas, Terri E Gibson, Theresa Kirkham (NMI), Thomas J Arista, Torrance J Slayton, Tracy J Washington, Travis M Beard, Tricia S Martinez, Tuan A Nguyen, Vivian Garcia, William D Bassett, Jr, William H Shackelford, William V Millar, Xikui Chen (nmi), PhD, Young M Yoon, Zerita White, Zhong Li, PhD

Joel D Martinez's Documents

Publish Date	Document Type	Title
January, 2001	EIR	sanofi chimie - EIR, 2001-02-20
October, 2003	FDA 483 Response	Sherwyn L Schwartz, M.D. - Form 483R, 2003-10-22
November, 2004	FDA 483	Massimo Cristofanilli, MD - Form 483, 2004-11-03
August, 2004	EIR	Dr. Valdir Tadini - EIR, 2004-09-20
October, 2003	EIR	Sherwyn L Schwartz, M.D. - EIR, 2003-10-22
April, 2001	EIR	Dr. Trevor Winter - EIR, 2001-04-26
November, 2001	EIR	Francis X Burch, M.D. - EIR, 2001-11-29
November, 2000	FDA 483 Response	Scirex Corp - Form 483R, 2000-12-11
July, 2014	EIR	Alcon Research, LLC - EIR, 2014-07-24
May, 2014	FDA 483	Emanuel Calenoff, M.D. - Form 483, 2014-05-22
July, 2014	FDA 483	Alcon Research, LLC - Form 483, 2014-07-24
June, 2014	EIR	Mario R. Juarez, M.D./ Panacea Clinical Research - EIR, 2014-06-20
June, 2002	EIR	Patrick H Peters, Jr, MD - EIR, 2002-06-19
December, 2000	EIR	Central Texas Health Research - EIR, 2000-12-07
August, 2012	EIR	Richard L. Wasserman, M.D. - EIR, 2012-08-17
January, 2001	FDA 483	Krankenhaus der Barmherzigen - Form 483, 2001-01-19
February, 2002	EIR	David H Gordon, MD - EIR, 2002-02-28
October, 2018	FDA 483	Worldwide Clinical Trials Early Phase Services, LLC - Form 483, 2018-10-17
June, 2000	EIR	Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. - EIR, 2000-06-30
June, 2014	FDA 483	Mario R. Juarez, M.D./ Panacea Clinical Research - Form 483, 2014-06-20
March, 2013	EIR	Burzynski Research Institute - EIR, 2013-03-15
March, 2015	FDA 483	S.R. Burzynski Manufacturing Facility - Form 483, 2015-03-19
January, 2001	EIR	Dr. H. Jakubek - EIR, 2001-02-20
January, 2000	FDA 483 Response	Herve Sors M.D. - Form 483R, 2000-05-24
April, 2000	EIR	KP Ganeshappa, MD - EIR, 2000-04-13
February, 2003	FDA 483	Valley Retina Institute - Form 483, 2003-02-28
September, 2006	FDA 483	INCELL Corporation LLC - Form 483, 2006-09-19
October, 2001	EIR	Thomas C Vaughn, MD - EIR, 2001-10-09
January, 2001	EIR	Dr. M. Fouche - EIR, 2001-02-20
February, 2002	EIR	BRI Institutional Review Board, Inc. - EIR, 2002-02-15
May, 2014	FDA 483	ICON Early Phase Services, LLC - Form 483, 2014-05-02
June, 2000	FDA 483	Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. - Form 483, 2000-06-30
February, 2002	FDA 483	BRI Institutional Review Board, Inc. - Form 483, 2002-02-15
May, 2014	EIR	Emanuel Calenoff, M.D. - EIR, 2014-05-22
January, 2001	FDA 483 Response	Dr. H. Jakubek - Form 483R, 2001-02-06
August, 2000	FDA 483	The University of Oklahoma - Form 483, 2000-08-04
March, 2013	FDA 483	Burzynski Research Institute - Form 483, 2013-03-15
November, 2011	FDA 483	Norman Kalmin, M.D. - Form 483, 2011-11-09
May, 2001	FDA 483 Response	Dr. Gordon Greenberg - Form 483R, 2001-05-16
November, 2004	EIR	Massimo Cristofanilli, MD - EIR, 2004-11-03
August, 2003	EIR	Dr. Salman Al-Shukri - EIR, 2003-09-11
January, 2000	EIR	Mark S Kipnes, Dr/Clinv - EIR, 2000-01-06
June, 2015	FDA 483	Biocon Biologics Limited - Form 483, 2015-06-16
November, 2004	FDA 483	MD Anderson Cancer Center - Form 483, 2004-11-02
August, 2001	FDA 483	Stanislaw R Burzynski, MD - Form 483, 2001-08-10
June, 2016	FDA 483	Richard A. Pollak, DPM - Form 483, 2016-06-02
May, 2001	EIR	Dr. Gordon Greenberg - EIR, 2001-06-01
October, 2000	EIR	William C Campainge, DVM/Clinv - EIR, 2000-10-10
June, 2001	EIR	Michael T. Jarratt, MD - EIR, 2001-06-21
October, 2015	FDA 483 Response	Marc H. Weiner, M.D. - Form 483R, 2015-10-16
April, 2002	EIR	Richard M Evans, MD - EIR, 2002-04-01
September, 2006	EIR	UTMB-Galveston - EIR, 2006-09-29
May, 2017	FDA 483	Michael G. Winnie, M.D./ 3rd Coast Research Associates - Form 483, 2017-05-10
March, 2013	FDA 483	Stanislaw R Burzynski, MD - Form 483, 2013-03-15
February, 2000	EIR	Michael Rud Lassen M.D. - EIR, 2000-03-07
March, 2013	FDA 483 Response	Burzynski Research Institute - Form 483R, 2013-04-05
September, 2001	EIR	Matthew Medlock, MD - EIR, 2001-09-20
October, 2003	FDA 483	Sherwyn Schwartz MD - Form 483, 2003-10-22
May, 2001	FDA 483	Mount Sinai Hospital - Form 483, 2001-05-10
December, 2002	FDA 483	International Association for Colon Hydrotherapy - Form 483, 2002-12-18
October, 2000	FDA 483	Urology San Antonio - Form 483, 2000-10-03
April, 2002	EIR	Francis X Burch, M.D. - EIR, 2002-04-18
November, 2001	FDA 483	San Antonio Center for Clinical Research - Form 483, 2001-11-29
April, 2000	FDA 483	Digestive Diseases Center - Form 483, 2000-04-13
July, 2014	FDA 483 Response	Alcon Research, LLC - Form 483R, 2014-08-14
July, 2009	EIR	Dowling ("Dow") B. Stough, IV, M.D. - EIR, 2009-07-24
February, 2003	FDA 483 Response	Victor Gonzalez, MD -Clinical Investigator - Form 483R, 2003-03-07
September, 2014	FDA 483	Stillmeadow Incorporated - Form 483, 2014-09-19
June, 2012	FDA 483	Mark S. Kipnes. M.D. - Form 483, 2012-06-27
March, 2001	EIR	Walter Chase, MD/Clin Inv - EIR, 2001-03-02
August, 2014	FDA 483 Response	Dr. Robert C. Read - Form 483R, 2014-09-04
August, 2014	FDA 483	Dr. Robert C. Read - Form 483, 2014-08-22
October, 2015	FDA 483	Marc H. Weiner, M.D. - Form 483, 2015-10-06
August, 2014	EIR	Dr. Robert C. Read - EIR, 2014-08-22
June, 2011	FDA 483	ICON Early Phase Services, LLC - Form 483, 2011-06-28
December, 2002	EIR	International Association for Colon Hydrotherapy - EIR, 2002-12-18
November, 2000	EIR	Scirex Corp - EIR, 2000-11-22
April, 2001	EIR	Dr. Trevor Winter - EIR, 2001-04-27
February, 2000	FDA 483 Response	Michael Rud Lassen M.D. - Form 483R, 2000-05-04
January, 2002	EIR	David W. Brown, MD - EIR, 2002-01-19
March, 2002	FDA 483 Response	Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. - Form 483R, 2002-03-27
June, 2001	EIR	Paul Ratner, Dr/Clin Inv - EIR, 2001-06-07
November, 2004	EIR	MD Anderson Cancer Center - EIR, 2004-11-02
January, 2001	FDA 483 Response	Dr. M. Fouche - Form 483R, 2001-01-26
April, 2012	FDA 483	Celltex Therapeutics Corporation - Form 483, 2012-04-27
October, 2000	EIR	David R Talley, MD/Clin Inv - EIR, 2000-10-03
January, 2001	FDA 483	Polyclinique Sevigne - Form 483, 2001-01-26
February, 2003	EIR	Victor Gonzalez, MD -Clinical Investigator - EIR, 2003-02-28
March, 2011	EIR	PETNET SOLUTIONS, INC. - EIR, 2011-03-11
April, 2002	FDA 483	Medical Center Ophthalmology Associates - Form 483, 2002-04-01
August, 2006	EIR	Francis X Burch, M.D. - EIR, 2006-08-24
September, 2006	EIR	INCELL Corporation LLC - EIR, 2006-09-19
March, 2002	EIR	Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. - EIR, 2002-03-07
February, 2011	FDA 483	Worldwide Clinical Trials Early Phase Services, LLC - Form 483, 2011-02-17
January, 2001	FDA 483 Response	sanofi chimie - Form 483R, 2001-04-20
January, 2000	EIR	Herve Sors M.D. - EIR, 2000-01-28
November, 2000	FDA 483	Scirex Corp - Form 483, 2000-11-22
November, 2011	EIR	Norman Kalmin, M.D. - EIR, 2011-11-09
June, 2001	FDA 483	Michael T. Jarratt, MD - Form 483, 2001-06-21
October, 2016	FDA 483	Israel Hartman, M.D. - Form 483, 2016-10-28
May, 2002	EIR	Prof. Jean-Louis Balmes (Paille) - EIR, 2002-06-11
January, 2006	FDA 483	IRB for the Baylor College of Medicine - Form 483, 2006-01-11
March, 2013	EIR	Stanislaw R Burzynski, MD - EIR, 2013-03-15
October, 2018	EIR	Worldwide Clinical Trials Early Phase Services, LLC - EIR, 2018-10-17
March, 2002	FDA 483	Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. - Form 483, 2002-03-07
August, 2004	EIR	Dr. Carlos Isaia Filho - EIR, 2004-09-10
December, 2004	FDA 483	John R Graybill, Md - Form 483, 2004-12-20
September, 2005	EIR	Mark S. Lee, M.D. - EIR, 2005-09-22
March, 2013	FDA 483 Response	Stanislaw R Burzynski, MD - Form 483R, 2013-04-08
December, 2013	FDA 483	Worldwide Clinical Trials Early Phase Services, LLC - Form 483, 2013-12-20
September, 2006	FDA 483 Response	INCELL Corporation LLC - Form 483R, 2006-10-20
September, 2014	EIR	Stillmeadow Incorporated - EIR, 2014-09-19
August, 2003	FDA 483	Dr. Salman Al-Shukri - Form 483, 2003-08-07
March, 2000	EIR	Paul Ratner, Dr/Clin Inv - EIR, 2000-03-02
August, 2004	FDA 483	Prof. Dr. Valdir Tadini - Form 483, 2004-08-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more